DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



[Clinical observation of tramadol on postoperative painment from LASEK]

Author(s): Li Z, Wang P, Zhao R

Affiliation(s): Zhuhai Maternal and Child Health's Hospital, Zhuhai 519000, China.

Publication date & source: 2005-12, Yan Ke Xue Bao., 21(4):114-5, 123.

Publication type: English Abstract

PURPOSE: To evaluate the efficacy and safety of tramadol for controlling post-operative ocular pain from laser assisted subepithelial keratomileusis (LASEK). METHODS: A randomized and controlled study was used.Tramadol tablet is taken orally two times a day plus Tobradex and Diclofenac sodium eyedrops were administered four times a day to the study group and Tobradex and Diclofenac sodium eyedrops only were administered four times a day to the control group. Slitlamp biomicroscopy and clinical scoring (0 to 4) were used to assess pain, photophobia, tearing, stinging-burning (0 = no pain; 1 = mild pain; 2 = moderate pain; 3 = severes pain; 4 = very severe pain). The assessments were made at anterioroperation, 1 day, 4 days,7 days postoperatively. RESULTS: Post-operative pain cores for the study group and the control group were 0.48 +/- 0.67 and 1.70 +/- 0.69 (P < 0.001) at 1 day, 0.18 +/- 0.39 and 0.65 +/- 0.55 (P < 0.05) at 4 days, respectively. No severe complications were found in either group. CONCLUSION:tramadol plays an important role in efficacy and safety for controlling ocular pain and inflammation after LASEK.

Page last updated: 2007-02-12

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017